InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Adagio Medical Holdings, Inc.

ADGM Clue Score39
United States Fiscal year ends December CIK 0002006986
$0.13 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.13 −94.46% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 1 Aug 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue0.3Operating income−27.9Net income−36.6EPS, diluted−48.16Fiscal year 2024Fiscal year 2025Revenue0.0Operating income−21.9Net income−25.1EPS, diluted−1.51
FY2023FY2024FY2025
Revenue 0.3 n/a 0.0
Growth
Operating income −27.9 n/a −21.9
Net income −36.6 n/a −25.1
Growth
EPS, diluted −48.16 n/a −1.51
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2023Operating margin−9,314.0%Net margin−12,196.7%Free cash flow margin−8,661.7%Fiscal year 2024Fiscal year 2025
FY2023FY2024FY2025
Operating margin −9,314.0% n/a n/a
Net margin −12,196.7% n/a n/a
Free cash flow margin −8,661.7% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−25.7Capital expenditure−0.3Free cash flow−26.0Fiscal year 2024Fiscal year 2025Operating cash flow−19.0Capital expenditure−0.4Free cash flow−19.4
FY2023FY2024FY2025
Operating cash flow −25.7 n/a −19.0
Capital expenditure −0.3 n/a −0.4
Free cash flow −26.0 n/a −19.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2023Cash1.4Total debt38.3Net cash (debt)−36.9Shareholders’ equity−132.0Fiscal year 2024Cash20.6Total debt17.2Net cash (debt)3.4Shareholders’ equity19.9Debt to equity0.86Fiscal year 2025Cash17.1Total debt21.0Net cash (debt)−3.9Shareholders’ equity12.4Debt to equity1.70
FY2023FY2024FY2025
Cash 1.4 20.6 17.1
Total debt 38.3 17.2 21.0
Net cash (debt) −36.9 3.4 −3.9
Shareholders’ equity −132.0 19.9 12.4
Debt to equity n/a 0.86 1.70

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−25.7 n/a −19.0
Growth
0.5 n/a 1.0
Investment
−0.3 n/a −0.4
calc −26.0 n/a −19.4
Growth
calc n/a n/a −1.17
−0.3 n/a −0.4
Financing
21.9 n/a 16.1

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.